US Senator plans legislation to advance medical research

23 January 2015

In remarks at the Families USA Health Action Conference in Washington DC on January 22, US Senator Elizabeth Warren (Democrat, Massachusetts) announced plans to introduce new legislation to advance medical research.

She said: "The first problem is the government. Congress used to work in a non-political, bipartisan way to expand NIH [National Institutes of Health] funding. But since the early 2000s, Congress has been strangling the funding needed for medical research....The second problem is with the drug companies. Over the last 10 years, some of our wealthiest drug companies - those that capitalize on government research to generate billions of dollars in revenues through the sale of blockbuster drugs- have found another way to boost profits."

Sen Warren then laid out her plan to introduce a bill that would help strengthen the federal investment in critical medical research, saying: "Next week, I plan to introduce legislation - the Medical Innovation Act - that would substantially increase federal funding for the National Institutes of Health."

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical